EXPANESTHETICS, INC

Profile

Company Names

EXPANESTHETICS, INC

Addresses

1450 DREW AVE., SUITE 100, DAVIS, X1 95618

1260 LAKE BLVD., SUITE 231, DAVIS, X1 95616

Phone Numbers

8442987201

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

CALIFORNIA

Total Amount Raised:

$12,477,877.00

Number of Funding Rounds:

19
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
19
2023-12-04 
$234,260.00 
$234,260.00 
$0.00 
Equity 
18
2023-10-09 
$372,300.00 
$372,300.00 
$0.00 
Equity 
17
2023-07-05 
$282,338.00 
$282,338.00 
$0.00 
Equity 
16
2023-02-02 
$356,400.00 
$356,400.00 
$0.00 
Equity 
15
2023-01-25 
$20,496.00 
$20,496.00 
$0.00 
Equity 
14
2022-12-01 
$227,700.00 
$227,700.00 
$0.00 
Equity 
13
2022-05-13 
$554,233.00 
$554,233.00 
$0.00 
 
12
2021-12-22 
$1,292,646.00 
$1,292,646.00 
$0.00 
Equity 
11
2021-09-14 
$84,857.00 
$84,857.00 
$0.00 
Equity 
10
2021-04-30 
$823,108.00 
$823,108.00 
$0.00 
 
9
2020-09-09 
$219,604.00 
$219,604.00 
$0.00 
 
8
2020-09-08 
$342,640.00 
$342,640.00 
$0.00 
 
7
2020-06-08 
$260,897.00 
$260,897.00 
$0.00 
Equity 
6
2019-10-31 
$708,125.00 
$708,125.00 
$0.00 
Equity 
5
2019-04-24 
$769,091.00 
$769,091.00 
$0.00 
Equity 
4
2019-01-20 
$445,140.00 
$445,140.00 
$0.00 
 
3
2018-07-09 
$1,163,593.00 
$1,163,593.00 
$0.00 
 
2
2017-09-14 
$1,393,561.00 
$1,393,561.00 
$0.00 
Equity 
1
2013-12-20 
$2,926,888.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHANE 
 
AUSTIN 
EXECUTIVE OFFICER
LANDON 
 
ELLIS 
EXECUTIVE OFFICER
RICHARD 
 
FOWLER 
DIRECTOR
JENNA 
 
HANSEN 
DIRECTOR
LON 
 
HATAMIYA 
DIRECTOR
MARK 
 
HOLMAN 
EXECUTIVE OFFICER, DIRECTOR
CLAIRE 
 
POMEROY 
DIRECTOR
TODD 
 
STRUMWASSER 
DIRECTOR
BRIAN 
 
WOODALL 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2023-10-09 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2023-12-04 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2023-07-05 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2023-01-25 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2023-02-02 
D
PHARMACEUTICALS 
 
NO REVENUES 
 
2022-05-13 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2022-12-01 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-12-22 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-09-14 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-09-14 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
 
2021-04-30 
D
PHARMACEUTICALS 
 
NO REVENUES 
 
2021-04-30 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
 
2020-09-08 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
 
2020-09-09 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
 
2020-09-09 
D
PHARMACEUTICALS 
 
NO REVENUES 
 
2020-09-09 
D
PHARMACEUTICALS 
 
NO REVENUES 
 
2020-09-08 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-04-24 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2020-06-08 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-10-31 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-10-31 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-04-24 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-04-24 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
 
2018-07-09 
D
PHARMACEUTICALS 
 
NO REVENUES 
 
2019-01-20 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2017-09-14 
D
PHARMACEUTICALS 
 
NO REVENUES 
 
2018-07-09 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2017-09-14 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2013-12-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE